| scholarly article | Q13442814 |
| P2093 | author name string | Masahiro Murakami | |
| Rei Ogawa | |||
| Ghazizadeh Mohammad | |||
| Hiroaki Kuwahara | |||
| Mamiko Tosa | |||
| Seiko Egawa | |||
| P2860 | cites work | The basics of epithelial-mesenchymal transition | Q24652992 |
| Epithelial-mesenchymal transitions in tumour progression | Q27860487 | ||
| Sorafenib in advanced clear-cell renal-cell carcinoma | Q28282767 | ||
| Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix | Q29619797 | ||
| Keloid pathogenesis and treatment | Q33231291 | ||
| Epithelial to mesenchymal transition in human skin wound healing is induced by tumor necrosis factor-alpha through bone morphogenic protein-2. | Q33816329 | ||
| Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states | Q34406761 | ||
| Current concepts in the etiology and treatment of keloids | Q34425951 | ||
| TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease | Q34581113 | ||
| Transitions between epithelial and mesenchymal states in development and disease | Q34761972 | ||
| Keloid-derived keratinocytes acquire a fibroblast-like appearance and an enhanced invasive capacity in a hypoxic microenvironment in vitro | Q35234265 | ||
| Identification and characterization of a fibroblast marker: FSP1 | Q36382596 | ||
| Sorafenib for the treatment of advanced renal cell carcinoma | Q36692604 | ||
| Sorafenib ameliorates bleomycin-induced pulmonary fibrosis: potential roles in the inhibition of epithelial-mesenchymal transition and fibroblast activation | Q36973713 | ||
| Direct contribution of epithelium to organ fibrosis: epithelial-mesenchymal transition | Q37583186 | ||
| Transforming growth factor-beta signaling in epithelial-mesenchymal transition and progression of cancer | Q37616967 | ||
| Secreted frizzled related protein 1 modulates taxane resistance of human lung adenocarcinoma | Q37728993 | ||
| Epithelial-mesenchymal transition in the skin | Q37822052 | ||
| Scar wars: mapping the fate of epithelial-mesenchymal-myofibroblast transition | Q37856705 | ||
| Keloids and hypertrophic scars: update and future directions. | Q38257534 | ||
| Epidermal organization and differentiation of HaCaT keratinocytes in organotypic coculture with human dermal fibroblasts | Q40966333 | ||
| Identification and characterization of Wnt signaling pathway in keloid pathogenesis | Q41507378 | ||
| Hypertrophic scars, keloids, and contractures. The cellular and molecular basis for therapy | Q41508533 | ||
| Epithelial-mesenchymal interactions in keloid pathogenesis modulate vascular endothelial growth factor expression and secretion | Q42504870 | ||
| A novel family of cyclic peptide antagonists suggests that N-cadherin specificity is determined by amino acids that flank the HAV motif | Q42805775 | ||
| Epithelial-mesenchymal transition of the eccrine glands is involved in skin fibrosis in morphea. | Q45911889 | ||
| Conditioned medium from keloid keratinocyte/keloid fibroblast coculture induces contraction of fibroblast-populated collagen lattices. | Q51497321 | ||
| Keratinocytes promote proliferation and inhibit apoptosis of the underlying fibroblasts: an important role in the pathogenesis of keloid. | Q51785180 | ||
| Epithelial-mesenchymal transition in keloid tissues and TGF-β1-induced hair follicle outer root sheath keratinocytes. | Q53482048 | ||
| Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. | Q53547282 | ||
| Fibroblasts emerge via epithelial-mesenchymal transition in chronic kidney fibrosis | Q58214788 | ||
| The morphological and molecular features of the epithelial-to-mesenchymal transition | Q59123131 | ||
| Biological differences between fibroblasts derived from peripheral and central areas of keloid tissues | Q80798686 | ||
| ADH-1 suppresses N-cadherin-dependent pancreatic cancer progression | Q80848915 | ||
| Interleukin-18 system plays an important role in keloid pathogenesis via epithelial-mesenchymal interactions | Q82325864 | ||
| Expression of SNAI1 and TWIST1 in the eccrine glands of patients with systemic sclerosis: possible involvement of epithelial-mesenchymal transition in the pathogenesis | Q82332272 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e1138 | |
| P577 | publication date | 2016-11-28 | |
| P1433 | published in | Plastic and reconstructive surgery. Global open | Q27725386 |
| P1476 | title | Examination of Epithelial Mesenchymal Transition in Keloid Tissues and Possibility of Keloid Therapy Target | |
| P478 | volume | 4 |
| Q64921833 | Hypoxia-Induced Epithelial-To-Mesenchymal Transition Mediates Fibroblast Abnormalities via ERK Activation in Cutaneous Wound Healing. |
| Q91899208 | In Vitro and Ex Vivo Models for Functional Testing of Therapeutic Anti-scarring Drug Targets in Keloids |
| Q94673354 | Pirfenidone inhibits epithelial-mesenchymal transition in keloid keratinocytes |
| Q92879280 | Regeneration of Dermis: Scarring and Cells Involved |
| Q96304791 | The Keloid Disorder: Heterogeneity, Histopathology, Mechanisms and Models |
Search more.